Increased Iron Requirement in Hemodialysis Patients on Antiplatelet Agents or Warfarin

Publisher： Karger

E-ISSN： 1660-2110|113|1|c38-c45

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.113, Iss.1, 2009-07, pp. : c38-c45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Iron Sucrose in Hemodialysis Patients Intolerant to Other Parenteral Iron Products

By  

Nephron Clin Pract, Vol. 96, Iss. 2, 2004-11 ,pp. : c63-c66

Karger

Access to resources Recommend Favorite

Effects of Intravenously Administered Iron on Systemic Blood Pressure in Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 98, Iss. 3, 2004-11 ,pp. : c83-c86

Karger

Access to resources Recommend Favorite

Acute Oxidative Stress following Intravenous Iron Injection in Patients on Chronic Hemodialysis: A Comparison of Iron-Sucrose and Iron-Dextran

By  

Nephron Clin Pract, Vol. 118, Iss. 3, 2010-12 ,pp. : c249-c256

Karger

Access to resources Recommend Favorite

Following JGES guidelines for patients with antiplatelet agents might increase bleeding after gastric endoscopic submucosal dissection

By  

DIGESTIVE ENDOSCOPY, Vol. 27, Iss. 6, 2015-09 ,pp. : 711-711

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery

By Ho H.   Lau T.   Leung F.   Tse H-F.   Siu C-W.  

Osteoporosis International, Vol. 21, Iss. 4, 2010-12 ,pp. : 573-577

Springer Publishing Company

Access to resources Recommend Favorite